209 related articles for article (PubMed ID: 23038092)
1. High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation.
Kamioka M; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
Int Heart J; 2012; 53(5):306-12. PubMed ID: 23038092
[TBL] [Abstract][Full Text] [Related]
2. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients.
Kaneshiro T; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
Int Heart J; 2012; 53(4):249-52. PubMed ID: 22878804
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effects of cardiac resynchronization therapy on pathophysiological pathways of heart failure using surrogate biomarkers.
Sunman H; Özkan A; Yorgun H; Canpolat U; Karabulut E; Bayrak T; Kaya EB; Tokgözoğlu L; Özer N; Özkara A; Aytemir K; Oto A
Cardiol J; 2018; 25(1):42-51. PubMed ID: 28980281
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.
Lellouche N; De Diego C; Cesario DA; Vaseghi M; Horowitz BN; Mahajan A; Wiener I; Boyle NG; Fonarow GC; Shivkumar K
Am J Cardiol; 2007 Jan; 99(2):242-6. PubMed ID: 17223426
[TBL] [Abstract][Full Text] [Related]
5. Impact of cardiac resynchronization therapy on inflammatory biomarkers and cardiac remodeling: The paradox of functional and echocardiographic response.
Almeida-Morais L; Abreu A; Oliveira M; Silva Cunha P; Rodrigues I; Portugal G; Rio P; Soares R; Mota Carmo M; Cruz Ferreira R
Rev Port Cardiol (Engl Ed); 2018 Feb; 37(2):105-113. PubMed ID: 29503051
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
El-Saed A; Voigt A; Shalaby A
Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
[TBL] [Abstract][Full Text] [Related]
7. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
[TBL] [Abstract][Full Text] [Related]
8. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory activation following interruption of long-term cardiac resynchronization therapy.
Rubaj A; Ruciński P; Oleszczak K; Trojnar MK; Wójcik M; Wysokiński A; Kutarski A
Heart Vessels; 2013 Sep; 28(5):583-8. PubMed ID: 23242167
[TBL] [Abstract][Full Text] [Related]
11. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
12. The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
Rickard J; Popovic Z; Verhaert D; Sraow D; Baranowski B; Martin DO; Lindsay BD; Varma N; Tchou P; Grimm RA; Wilkoff BL; Chung MK
Pacing Clin Electrophysiol; 2011 May; 34(5):604-11. PubMed ID: 21276023
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.
Frigerio M; Lunati M; Pasqualucci D; Vargiu S; Foti G; Pedretti S; Vittori C; Cattafi G; Magenta G; Campo C; Bisetti S; Mercuro G
Int J Cardiol; 2014 Mar; 172(1):64-71. PubMed ID: 24456869
[TBL] [Abstract][Full Text] [Related]
14. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
[TBL] [Abstract][Full Text] [Related]
16. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
[TBL] [Abstract][Full Text] [Related]
18. Tighter is better: Can a simple and cost-free parameter predict response to cardiac synchronization therapy?
Coppola G; Madaudo C; Mascioli G; D'Ardia G; Greca C; Prezioso A; Corrado E
Pacing Clin Electrophysiol; 2024 Jul; 47(7):966-973. PubMed ID: 38830778
[TBL] [Abstract][Full Text] [Related]
19. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
[TBL] [Abstract][Full Text] [Related]
20. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
